Centers for Disease Control and Prevention. Surveillance for diabetes mellitus—United States, 1980-1989,
and laboratory-based surveillance for meningococcal disease in selected areas—United
States, 1989-1991. MMWR Morb Mortal Wkly Rep.1993;42(SS-2):21-30.
Jackson LA, Schuchat A, Reeves MW, Wenger JD. Serogroup C meningococcal outbreaks in the United States: an emerging
Centers for Disease Control and Prevention. Control and prevention of serogroup C meningococcal disease: evaluation and management of suspected outbreaks: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep.1997;46:13-21.
Selander RK, Caugant DA, Ochman H.
et al. Methods of multilocus enzyme electrophoresis for bacterial population
genetics and systematics. Appl Environ Microbiol.1986;51:873-884.
Caugant DA, Mocca LF, Frasch CE.
et al. Genetic structure of Neisseria meningitidis
populations in relation to serogroup, serotype, and outer membrane protein
pattern. J Bacteriol.1987;169:2781-2792.
Woods TC, Helsel LO, Swaminathan B. Characterization of Neisseria meningitidis
serogroup C by multilocus enzyme electrophoresis and ribosomal DNA restriction
profiles. J Clin Microbiol.1992;30:132-137.
Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine efficacy in the field. Epidemiol Rev.1988;10:212-241.
Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika.1986;73:13-22.
Gold R, Lepow ML, Goldschneider I.
et al. Clinical evaluation of group A and group C meningococcal polysaccharide
vaccines in infants. J Clin Invest.1975;56:1536-1547.
Ashton FE, Ryan JA, Borczyk A.
et al. Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease
in Canada. J Clin Microbiol.1991;29:2489-2492.
Fischer M, Hedberg K, Cardosi P.
et al. Tobacco smoke as a risk factor for meningococcal disease. Pediatr Infect Dis J.1997;16:979-983.
Whitney CG, Dondoc N, Enktuja B.
et al. Efficacy of Neisseria meningitidis serogroup
A/C polysaccharide vaccine among children in Mongolia. In: Programs and abstracts of the 10th International
Conference; September 8-13, 1996; Baltimore, Md.
Artenstein MS, Gold R, Zimmerly JG.
et al. Prevention of meningococcal disease by group C polysaccharide vaccine. N Engl J Med.1970;282:417-420.
Gold R, Artenstein MS. Meningococcal infections, 2: field trial of group C meningococcal polysaccharide
vaccine in 1969-70. Bull World Health Organ.1971;45:279-282.
Biselli R, Fattorossi A, Matricardi PM.
et al. Dramatic reduction of meningococcal meningitis among military recruits
in Italy after introduction of specific vaccination. Vaccine.1993;11:578-581.
Taunay AE, Feldman RA, Bactos CO.
et al. Assessment of the protection conferred by anti-group C meningococcal
polysaccharide vaccine to 6 to 36 month-old children. Rev Inst Adolfo Lutz.1978;38:77-82.
De Wals P, Dionne M, Douville-Fradet M.
et al. Impact of a mass immunization campaign against serogroup C meningococcus
in the Province of Quebec, Canada. Bull World Health Organ.1996;74:407-411.
Adams WG, Deaver KA, Cochi SL.
et al. Decline of childhood Haemophilus influenzae
type b disease in the Hib vaccine era. JAMA.1993;269:221-226.
Gotschlich EC, Goldschneider I, Artenstein S. Human immunity to the meningococcus. J Exp Med.1969;129:1385-1395.
Moore PS, Harrison LH, Telzak EE.
et al. Group A meningococcal carriage in travelers returning from Saudi Arabia. JAMA.1988;260:2686-2689.
Blakesbrough IS, Greenwood BM, Whittle HC, Bradley AK. Failure of meningococcal vaccination to stop the transmission of meningococci
in Nigerian schoolboys. Ann Trop Med Parasitol.1983;77:175-178.
Hassan-King MKA, Wall RA, Greenwood BM. Meningococcal carriage, meningococcal disease and vaccination. J Infect.1988;16:55-59.
Imrey PB, Jackson LA, Ludwinski PH.
et al. Outbreak of serogroup C meningococcal disease associated with campus
bar patronage. Am J Epidemiol.1996;143:624-630.
Le Saux N, Ashton F, Rahman M.
et al. Carriage of Neisseria species in communities
with different rates of meningococcal disease. Can J Infect Dis.1992;3:60-64.
Tappero JW, Reporter R, Wenger JD.
et al. Meningococcal disease in Los Angeles County, California, and among
men in the county jails. N Engl J Med.1996;335:833-840.
Lieberman JM, Chiu SS, Wong VK.
et al. Safety and immunogenicity of serogroups A/C Neisseria
meningitidis oligosaccharide-protein conjugate vaccine in young children. JAMA.1996;275:1499-1503.
Roberts CL, Roome A, Algert CS.
et al. A meningococcal vaccination campaign on a university campus. Am J Public Health.1996;86:1155-1158.